101 related articles for article (PubMed ID: 31362570)
21. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
22. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.
Choi S; Kim SW; Kim HS
Cancer Genomics Proteomics; 2021; 18(5):685-698. PubMed ID: 34479920
[TBL] [Abstract][Full Text] [Related]
23. Cervical Adenosquamous Carcinoma: Detailed Analysis of Morphology, Immunohistochemical Profile, and Outcome in 59 Cases.
Stolnicu S; Hoang L; Zhou Q; Iasonos A; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA
Int J Gynecol Pathol; 2023 May; 42(3):259-269. PubMed ID: 36044310
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
25. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
[TBL] [Abstract][Full Text] [Related]
26. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas.
Emerson RE; Michael H; Wang M; Zhang S; Roth LM; Cheng L
Int J Gynecol Pathol; 2016 Jul; 35(4):372-84. PubMed ID: 26630233
[TBL] [Abstract][Full Text] [Related]
27. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
[TBL] [Abstract][Full Text] [Related]
28. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
29. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.
Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
Ann Oncol; 2009 Jan; 20(1):63-70. PubMed ID: 18689863
[TBL] [Abstract][Full Text] [Related]
31. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy of HPV DNA in cervical cancer.
Cheung TH; Yim SF; Yu MY; Worley MJ; Fiascone SJ; Chiu RWK; Lo KWK; Siu NSS; Wong MCS; Yeung ACM; Wong RRY; Chen ZG; Elias KM; Chung TKH; Berkowitz RS; Wong YF; Chan PKS
J Clin Virol; 2019 May; 114():32-36. PubMed ID: 30913520
[TBL] [Abstract][Full Text] [Related]
34. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin.
Grayson W; Taylor LF; Cooper K
Am J Surg Pathol; 1999 Apr; 23(4):448-58. PubMed ID: 10199475
[TBL] [Abstract][Full Text] [Related]
35. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
36. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
38. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
39. Differences between cell lines of uterine cervical glassy cell carcinoma and large cell nonkeratinizing squamous cell carcinoma.
Ishiwata I; Ishiwata C; Soma M; Ono I; Nakaguchi T; Nozawa S; Ishikawa H
Anal Quant Cytol Histol; 1990 Aug; 12(4):290-8. PubMed ID: 1698374
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
